ライフサイエンスコーパス: phosphate-buffered saline

1 obtained compared to result obtained in PBS (phosphate buffered saline).

2 e IgG2alpha Fc fragment (Ad Fc), or vehicle (phosphate-buffered saline).

3 specific and little non-specific binding in phosphate buffered saline.

4 via a sandwich immunoassay for human IgG in phosphate buffered saline.

5 up was injected with MTX (1.0 mg/kg/week) in phosphate buffered saline.

6 25 head and neck squamous carcinoma cells in phosphate buffered saline.

7 tection limit of 500 muM in water and 1mM in phosphate buffered saline.

8 , nonpretargeted (177)Lu-IMP288 (60 MBq), or phosphate-buffered saline.

9 n 50 muL phosphate-buffered saline or 50 muL phosphate-buffered saline.

10 axane (25 mg/kg every other day, 3 doses) or phosphate-buffered saline.

11 /d), AG490, a JAK2 inhibitor (5 mg/kg/d), or phosphate-buffered saline.

12 d incubated with either 75 microM ammonia or phosphate-buffered saline.

13 incubating celecoxib and melanin in isotonic phosphate-buffered saline.

14 to the Con A concentration up to 10(-7) M in phosphate-buffered saline.

15 ith OVA, compared with controls treated with phosphate-buffered saline.

16 animal (RRV) or human (HAL1166) rotavirus or phosphate-buffered saline.

17 o bovine serum and in 9 days when exposed to phosphate-buffered saline.

18 in group 4 served as controls and were given phosphate-buffered saline.

19 ension of positive fecal and bile samples in phosphate-buffered saline.

20 s twice at a 9-day interval with SYI or with phosphate-buffered saline.

21 eached as low as 3.5x10(1)CFUmL(-1) in 0.01M phosphate-buffered saline.

22 py alone, (c) RF hyperthermia alone, and (d) phosphate-buffered saline.

23 erapy only, (c) RF hyperthermia only, or (d) phosphate-buffered saline.

24 h; sham controls received an equal volume of phosphate-buffered saline.

25 ce treated with a scrambled-sequence PPMO or phosphate-buffered saline.

26 in all groups were agitated for 3 minutes in phosphate-buffered saline.

27 Outflow facility for phosphate-buffered saline (0.0027 +/- 0.00036 muL/min/mm

28 in vivo compared to in vitro using agitated phosphate buffered saline +0.02% Tween 80 pH7.4, includi

29 Myocardial retention of cells suspended in phosphate-buffered saline 1 h after delivery was 17.6 +/

30 BALB/c mice received LAIV or phosphate-buffered saline 1 or 7 days before or during p

31 LAD (100 microg/mouse intraperitoneally), or phosphate buffered saline (100 microl/mouse intraperiton

32 Cys, a synthetic ligand of TLR2, or vehicle (phosphate-buffered saline) 24 h prior to Staphylococcus

33 em of acellular agarose disks and dextran in phosphate-buffered saline (3 and 70 kDa).

34 Median survival for the groups treated with phosphate-buffered saline, 6 MBq (213)Bi-IMP288, 12 MBq

35 lutathione-S-transferase (rGST)-adjuvant and phosphate-buffered saline-adjuvant served as nonvaccinat

36 The reaction was efficient in phosphate buffered saline and a wide range of biological

37 We have calibrated the sensor using phosphate buffered saline and demonstrated trace detecti

38 and interlaboratory measurements, samples of phosphate buffered saline and urine, spiked with differe

39 erate, and severe asthma were processed with phosphate-buffered saline and assayed for eotaxin by ELI

40 d 2-[(131) I] exhibit good stability in both phosphate-buffered saline and blood serum.

41 t IL-22 or anti-IL-22 neutralizing antibody; phosphate-buffered saline and IgG served as respective c

42 ntly enhanced analytical performance in both phosphate-buffered saline and plasma (6-20x improvement

43 4.5 and 7.2, (2) physiologic salt solutions (phosphate-buffered saline and saline) commonly used for

44 ated mice compared to those in animals given phosphate-buffered saline and then infected with the bac

45 thod is approximately 1 IU/mL (2 nM) in both phosphate-buffered saline and urine samples, and only 0.

46 pyridine analogues were more soluble in both phosphate-buffered saline and water.

47 inal Dryvax diluent, new Dryvax diluent, and phosphate-buffered saline), and temperature (refrigerato

48 demonstrated that a mixture of zinc sulfate, phosphate-buffered saline, and bovine serum albumin adde

49 omers enables robust cross-linking in water, phosphate-buffered saline, and cell culture medium to af

50 be delivered in a commercial moisturizer or phosphate-buffered saline, and do not require barrier di

51 us molecular weights (MWT) were dissolved in phosphate-buffered saline, and the rate of transretinal

52 temically administered (64)CuCl2 (74 MBq) or phosphate-buffered saline, and tumor sizes were monitore

53 the animals were compared to mock-immunized (phosphate-buffered saline) animals after bacterial chall

54 ion of infection compared to mock-immunized (phosphate-buffered saline) animals.

55 .0078mg/ml of T24 (Grade III) cell lysate in phosphate buffered saline, artificial urine and human ur

56 nose-6-Phosphate (29 animals), or 100 mul of phosphate buffered saline as a placebo control (29 anima

57 lated with herpes simplex virus 1 (HSV-1) or phosphate-buffered saline as a control.

58 determinations were lower in both saline and phosphate-buffered saline as compared to vaginal fluid m

59 Ten pigs in group 1 received phosphate-buffered saline as negative controls.

60 Group 1 pigs received phosphate-buffered saline as the negative control.

61 Mice were treated with phosphate buffered saline (as vehicle control), dexameth

62 g/kg bodyweight intraperitoneal) or vehicle (phosphate-buffered saline) as control.

63 obular proteins, such as hen egg lysozyme in phosphate buffered saline at room temperature, lose nati

64 dies of Abeta(1-40) amyloid fibrils grown in phosphate-buffered saline at 37 degrees C under unstirre

65 Release studies were conducted in phosphate-buffered saline at 37 degrees C with continuou

66 Release studies were conducted in phosphate-buffered saline at 37 degrees C with continuou

67 formed soluble aggregates upon dilution into phosphate-buffered saline at 37 degrees C.

68 or A beta(1-40) amyloid fibril elongation in phosphate-buffered saline at 37 degrees C.

69 ells were formed into pellets and covered in phosphate-buffered saline at room temperature for 56 h.

70 . cenocepacia strain BC7 suspended in either phosphate-buffered saline (BC7/PBS) or P. aeruginosa alg

71 littermates received intraperitoneal nIgM or phosphate-buffered saline/bovine serum albumin/immunoglo

72 approximately 5fg/ml for assays conducted in phosphate buffered saline buffer (PBS) and approximately

73 of 0.5-10 mL containing 5-1000 ppb TNT in a phosphate-buffered saline buffer were preconcentrated in

74 ration of TT30 were unaffected by citrate or phosphate-buffered saline buffers and indicate an elonga

75 d stability of these probes were assessed in phosphate-buffered saline, cell culture medium, rat seru

76 paB and 12 serum cytokines (p < or = .05 vs. phosphate-buffered saline challenge, except for interleu

77 s (6.1 +/- 0.5 %ID/cm(3)) when compared with phosphate-buffered saline-challenged animals (4.6 +/- 0.

78 emotherapy alone, RF hyperthermia alone, and phosphate-buffered saline, combination therapy with RF h

79 emotherapy alone, RF hyperthermia alone, and phosphate-buffered saline, combination therapy with RF h

80 et for 12 weeks, then administered rIL-19 or phosphate-buffered saline concomitant with Western diet

81 Cells suspended in phosphate-buffered saline consumed 2 mol of H2 per mol o

82 the HIV-1 RNA level in cervicovaginal fluid, phosphate-buffered saline containing 10 mM LiCl was used

83 An investigation of drug release kinetics in phosphate-buffered saline containing Tween 80 led us to

84 tumor growth compared with mice treated with phosphate-buffered saline-containing liposomes (P<0.001)

85 Afterwards, 5 x 10(5) CSCs (n = 30) or phosphate-buffered saline control (n = 15) was injected

86 dose of 20 mg/kg orally twice daily (n=7) or phosphate-buffered saline control (n=6) orally for 7 day

87 matory cytokines when compared with mock and phosphate-buffered saline control animals.

88 lation did not enhance colonization versus a phosphate-buffered saline control.

89 l suspension of liposomes coated with either phosphate-buffered saline (control) or clodronate (a mac

90 oom temperature for 4h in human plasma or in phosphate-buffered saline (control).

91 s, eyes received 5 microL of either Dulbecco phosphate-buffered saline (D-PBS), 10 microM D9R, or 100

92 enge, 15 of 16 mice who were inoculated with phosphate-buffered saline developed lesions, one dose of

93 thymocytes, primary necrotic thymocytes, or phosphate-buffered saline did not.

94 hat were vaccinated with a control strain or phosphate-buffered saline died.

95 controlling the concentration of Dulbecco's phosphate buffered saline (DPBS) electrolyte, the double

96 bacterial endotoxin contained in Dulbecco's phosphate-buffered saline (DPBS), a cohesive OVD, and a

97 Conjugates injected subcutaneously in phosphate-buffered saline elicited immunoglobulin G (IgG

98 herent on a quartz substrate in a deuterated phosphate-buffered saline environment at room temperatur

99 ation of 760+/-160 pM (120+/-25 ngml(-1)) in phosphate-buffered saline, falling to 2.5+/-0.7 nM (380+

100 cross-sections of brushite cylinders aged in Phosphate Buffered Saline, Foetal Bovine Serum, Dulbecco

101 ology and immunohistochemistry, the other in phosphate buffered saline for flow cytometry.

102 ylate (100 mg/kg three times weekly) or with phosphate-buffered saline for 4 to 6 wk.

103 The aerosol particles were then dispersed in phosphate-buffered saline for cytotoxicity and senescenc

104 TNNB1-LNP), scrambled sequence (Scr-LNP), or phosphate-buffered saline for multiple cycles.

105 c adenocarcinoma cell line Pan02 (cancer) or phosphate-buffered saline (healthy).

106 per day) into the right eyes in 20 rats and phosphate-buffered saline in 20 control rats was started

107 formed different complexes in serum than in phosphate-buffered saline in terms of both size and affi

108 ultipotent stem cells, or the same volume of phosphate-buffered saline in the peri-infarct area.

109 0 mM ribose in either serum ultrafiltrate or phosphate-buffered saline in the presence of various con

110 nm and 25-30 nm, respectively, took place in phosphate-buffered saline, in sucrose solution, and in w

111 xhibited excellent analytical performance in phosphate buffered saline, including a NO sensitivity of

112 human amniotic mesenchymal stromal cells or phosphate-buffered saline infused intracerebroventricula

113 28 days, compared with both sham-treated and phosphate-buffered saline-infused infarcted hearts, and

114 mucosa between the molars; and 6) group I-V: phosphate-buffered saline injected into the palatal muco

115 atment groups were compared with age-matched phosphate-buffered saline-injected control transgenic an

116 led animals receiving intravenous vehicle or phosphate-buffered saline-instilled animals receiving me

117 ol virus without insert, or control vehicle (phosphate buffered saline) intraarticularly before arthr

118 data with theoretical results suggests that phosphate-buffered saline is a good solvent for Q8 and Q

119 Mouse IgG diluted in phosphate-buffered saline is used as model target antige

120 nhancer of viral infection fibrils formed in phosphate buffered saline keep evolving after the initia

121 cells at room temperature or 4 degrees C in phosphate-buffered saline (labeling efficiency range, 13

122 assembly by injection from THF solution into phosphate-buffered saline led to unilamellar, monodisper

123 In phosphate buffered saline medium the actual lipophilicit

124 evels (i.e., 6-240 mg/dL) were quantified in phosphate-buffered saline medium using multivariate anal

125 othelial cells, n = 4) or control treatment (phosphate-buffered saline, n = 4) by means of imaging-gu

126 alone (200 million cells, n=5), or placebo (phosphate-buffered saline; n=5) was injected into the in

127 The models were exposed to phosphate buffered saline (negative control), triethylen

128 . paratuberculosis and PBMCs stimulated with phosphate-buffered saline (nil-stimulated PBMCs).

129 e injected i.p. with 50 or 250 mg/kg APAP or phosphate-buffered saline on gestation day 12.5; nonpreg

130 was observed in control mice immunized with phosphate-buffered saline only.

131 e arthritis compared with mice injected with phosphate buffered saline or control antibodies.

132 individuals by the oral route, mice were fed phosphate-buffered saline or 10(6)M. canettii mycobacter

133 tal fat-derived stem/stromal cells in 50 muL phosphate-buffered saline or 50 muL phosphate-buffered s

134 dium was truncated by switching the cells to phosphate-buffered saline or by the addition of antibiot

135 Phosphate-buffered saline or iPSC-w/o-c-Myc was then int

136 anti-GXM died earlier than mice treated with phosphate-buffered saline or irrelevant isotype-matched

137 s of mice received i.p. injections of either phosphate-buffered saline or L-N(6)-(1-iminoethyl) lysin

138 (OVA) at days 0 and 12, received intranasal phosphate-buffered saline or OVA challenges at days 24,

139 sensitized by intraperitoneal injections of phosphate-buffered saline or ovalbumin (OVA) at days 0 a

140 Formaldehyde, diluted in either phosphate-buffered saline or phosphate buffer, has been

141 addressed in murine airways challenged with phosphate-buffered saline or Pseudomonas aeruginosa.

142 e, which were challenged with OVA peptide or phosphate-buffered saline or remained untreated.

143 nction 2 weeks after transplant (hCPC versus phosphate-buffered saline, P<0.03).

144 ravenous injection of (n=10/group): Group 1: phosphate buffered saline (PBS 1 ml) for control.

145 r injections (50 microl/injection) of either phosphate buffered saline (PBS) (n = 9), human synoviocy

146 bilized antibodies on the ZnO surface in (i) phosphate buffered saline (PBS) and (ii) human serum.

147 Detection of cTnT in phosphate buffered saline (PBS) and human serum (HS) buf

148 anging from ~10(5) to 3.2 x 10(7) CFUs/mL in phosphate buffered saline (PBS) and peritoneal dialysis

149 e lateral motion with synovial fluid (SF) or phosphate buffered saline (PBS) as lubricant.

150 hest Q approximately 9300 in the bio-ambient phosphate buffered saline (PBS) as well as highest sensi

151 either Freund's incomplete adjuvant (IFA) or phosphate buffered saline (PBS) at monthly intervals.

152 rene (d(8)-PS) and SiO(2) model surfaces and phosphate buffered saline (PBS) at pH 7.4.

153 ns, and was found to be slowly degradable in phosphate buffered saline (PBS) but more rapidly degrade

154 ound to contain higher TPC, TFC and TCC than phosphate buffered saline (PBS) extracts for all the fru

155 particle loaded gels can release timolol in phosphate buffered saline (PBS) for about a month at roo

156 g was induced in one eye with glutaraldehyde/phosphate buffered saline (PBS) immersion while the othe

157 Incubation of the coated sensors in phosphate buffered saline (PBS) led to a monotonic incre

158 t between phospholipid bilayer membranes and phosphate buffered saline (PBS) medium (DMW,PBS) for 19

159 DF-1) versus a bolus application of SDF-1 in phosphate buffered saline (PBS) on wound healing was eva

160 re injected subcutaneously with bleomycin or phosphate buffered saline (PBS) once daily for 28 days.

161 tions of physiologic ionic strength, such as phosphate buffered saline (PBS) or 150 mM KCl.

162 pended inside a flowing medium that contains phosphate buffered saline (PBS) or whole blood.

163 lly captured and detected HIV-1 in serum and phosphate buffered saline (PBS) samples with viral loads

164 mplification at room temperature in 30min in phosphate buffered saline (PBS) solution.

165 ther with fibrocytes, dermal fibroblasts, or phosphate buffered saline (PBS) through tail vein inject

166 , we explore the effect of concentration for phosphate buffered saline (PBS), a typical ionic medium

167 anotubes were found not only to be stable to phosphate buffered saline (PBS), serum, and a variety of

168 ch resonances show high Q in the bio-ambient phosphate buffered saline (PBS).

169 ol mice were similarly injected with sterile phosphate buffered saline (PBS).

170 lized on a gold film in both air and flowing phosphate buffered saline (PBS).

171 a control vector with no insert (AxCANI), or phosphate buffered saline (PBS).

172 performed in physiological buffers, such as phosphate buffered saline (PBS).

173 R) at a diffusion-controlled rate in aerated phosphate buffered saline (PBS).

174 The films were shown to be stable in phosphate buffered saline (PBS).

175 ere performed at 37 degrees C in rat plasma, phosphate buffered saline (PBS, pH 7.4) and PB (pH 7.4).

176 release of 23% and 47% bound lactic acid in phosphate buffered saline (PBS, pH7.4) and acetate buffe

177 raarticular injections (50 mul/injection) of phosphate buffered saline (PBS; n = 14 rats) and human s

178 56days in various media: pH5.5, 6.5, and 7.4 phosphate buffered-saline (PBS) containing 0.02% Tween 8

179 imits ranging from 1 to 40 pg in 6 muL of 1x phosphate-buffered saline (PBS) (0.2-6 ng/mL) were achie

180 In the presence of 5 mM glucose in phosphate-buffered saline (PBS) (50 mM phosphate buffer

181 d in 50 mg/mL TCN solution (experimental) or phosphate-buffered saline (PBS) (control).

182 of transduced human MSCs suspended in either phosphate-buffered saline (PBS) (n = 4) or matrigel (n =

183 y with buffers A, B, and C, or separately by phosphate-buffered saline (PBS) alone.

184 n of the brain with cold or room temperature phosphate-buffered saline (PBS) also caused significant

185 d -25 degrees C for at least 3 days by using phosphate-buffered saline (PBS) and cysteine/methionine-

186 The detection curves were obtained in phosphate-buffered saline (PBS) and in undiluted artific

187 ts/mouse), lipopolysaccharide (2 microg), or phosphate-buffered saline (PBS) and sacrificed mice 24 h

188 niae were treated intravenously with PFCE or phosphate-buffered saline (PBS) and then managed in eith

189 tal recoveries obtained for all compounds in phosphate-buffered saline (PBS) and urine samples owing

190 jected intravenously with 3 x 10(6) hMSCs or phosphate-buffered saline (PBS) at 1 day after MCAo.

191 HDP-cyclic-CDV was suspended in phosphate-buffered saline (PBS) at 37 degrees C and form

192 es for the detection of nitric oxide (NO) in phosphate-buffered saline (PBS) at pH 7.4.

193 were injected with cultured mast cells or 1x phosphate-buffered saline (PBS) before collecting serum,

194 to ovalbumin (OVA-psigma1), psigma1 only, or phosphate-buffered saline (PBS) before oral challenge wi

195 pSHEV-1 triple mutant, wild-type pSHEV-3, or phosphate-buffered saline (PBS) buffer (n = 10).

196 CA15-3 detection was first characterized in phosphate-buffered saline (PBS) buffer and in fetal calf

197 Hydrolysis in pH 5.5 Mes and pH 7.2 phosphate-buffered saline (PBS) buffers was similar, but

198 Phosphate-buffered saline (PBS) containing celecoxib-PLG

199 In phosphate-buffered saline (PBS) containing EDTA, the apo

200 -2-infected guinea pigs compared to those of phosphate-buffered saline (PBS) control-vaccinated anima

201 ear in WT-infected mice did not differ from phosphate-buffered saline (PBS) controls or mice infecte

202 g) were randomly divided into three groups: phosphate-buffered saline (PBS) controls, PRARI controls

203 A plus Vaxfectin i.m. or 100 mug of DNA plus phosphate-buffered saline (PBS) i.m. using a needleless

204 in the presence of succinate, fumarate, and phosphate-buffered saline (PBS) in different cell models

205 Finally, experiments with phosphate-buffered saline (PBS) indicate that the films

206 rfusion of Adv.cmv.L-CPT1 (L-CPT1, n=15) vs. phosphate-buffered saline (PBS) infusion (PBS, n=7) or e

207 technique for cell-free virus elution using phosphate-buffered saline (PBS) may provide an alternati

208 erative subconjunctival injections of either phosphate-buffered saline (PBS) or 100 microM ilomastat

209 p was intravenously injected either with 2mL phosphate-buffered saline (PBS) or 3million hUTC in PBS

210 animals used as controls were injected with phosphate-buffered saline (PBS) or GBV-B, respectively.

211 olar lavage fluids from mice inoculated with phosphate-buffered saline (PBS) or S. aureus were deplet

212 ue-Dawley rats, 2 microg rhTSG-6 in 5-microL phosphate-buffered saline (PBS) or the same volume of on

213 th a S-OIV clinical isolate concentration in phosphate-buffered saline (PBS) over a range of 18-1.8 x

214 The LK14 peptide, adsorbed from a pH 7.4 phosphate-buffered saline (PBS) solution, displayed very

215 rythrocytes at 37 degrees C for up to 24h in phosphate-buffered saline (PBS) supplemented with 0 to 5

216 lity to recover DNA from Brucella species in phosphate-buffered saline (PBS) suspension and from spik

217 plification was achieved through dilution of phosphate-buffered saline (PBS) to tune Cdl to dominate

218 he appearance of tumor growth, compared with phosphate-buffered saline (PBS) treatment, but had no ef

219 Biliverdin (40 mg/kg) or phosphate-buffered saline (PBS) was administered either

220 As an internal control, phosphate-buffered saline (PBS) was similarly injected o

221 to 400 mg/dL or 0.10-10.34 mmol/L in 100 mM phosphate-buffered saline (PBS) without significant inte

222 Inhibition of alpha-toxin by phosphate-buffered saline (PBS), 0.1% methyl-beta-cyclod

223 Phosphate-buffered saline (PBS), 5x10(5) CD34+ cells/kg,

224 x 10(9) plaque-forming units of AdvBcl-2 in phosphate-buffered saline (PBS), AdvNull empty vector in

225 (PPSV23; Merck, Whitehouse Station, NJ), or phosphate-buffered saline (PBS), before corneal infectio

226 Compared with chronic infusions of phosphate-buffered saline (PBS), LPS infusions produced

227 reserved in diverse sample matrices, namely, phosphate-buffered saline (PBS), Middlebrook 7H9 medium

228 tion (BDL) for 14 days and were treated with phosphate-buffered saline (PBS), UDCA, all-trans retinoi

229 were attained for all the studied probes in phosphate-buffered saline (PBS), urine, and whole blood.

230 n mice that received the vaccine compared to phosphate-buffered saline (PBS)- and vector-treated cont

231 Here we report that a phosphate-buffered saline (PBS)-based nucleofection meth

232 lae were found in their spleens, unlike with phosphate-buffered saline (PBS)-dosed mice, and vaccinat

233 e exhibited a dermal architecture similar to phosphate-buffered saline (PBS)-injected control and nor

234 as 2.5-fold higher than in the contralateral phosphate-buffered saline (PBS)-injected eye (n = 6 rats

235 r 50 mg/kg per week), nontarget (NT) ASO, or phosphate-buffered saline (PBS).

236 ol mice were similarly injected with sterile phosphate-buffered saline (PBS).

237 oneal injection of either 5 g/kg of rhTrx or phosphate-buffered saline (PBS).

238 1% apoEdp, 1% trifluorothymidine (TFT), and phosphate-buffered saline (PBS).

239 njunctival injections of either ilomastat or phosphate-buffered saline (PBS).

240 ferritin Ab-functionalized microparticles in phosphate-buffered saline (PBS).

241 tions of VIPhyb (peptidic VIP-antagonist) or phosphate-buffered saline (PBS).

242 injection of 1 million human fibroblasts in phosphate-buffered saline (PBS); group 2, intravenous in

243 Phosphate-buffered saline (PBS, control, n=7) or 3x10(6)

244 obiota in two frequently used batch systems: phosphate-buffered saline (PBS, oligotrophic) and basal

245 ted 24 hours after intravitreal injection of phosphate-buffered saline (PBS, vehicle) or PBS + ouabai

246 ed daily intraperitoneal injections of TM or phosphate-buffered saline (PBS; control) through P17.

247 beta2-treated group), fetal calf serum (FCS)/phosphate-buffered saline (PBS; FCS/PBS-treated control

248 Control animals received phosphate-buffered saline (PBS; n = 5 to 7).

249 d pigs (n = 130) in one of four groups (PRCV/phosphate-buffered saline [PBS] [n = 41], PRCV/DEX [n =

250 RMG (but not in those vaccinated with REG or phosphate-buffered saline [PBS]) after homologous or het

251 (0.1% bovine serum albumin [BSA] in sterile phosphate-buffered saline [PBS]; 5 microl/mouse).

252 and their critical micelle concentrations in phosphate buffered saline (pH 7.4) are </=85 microg/mL.

253 ately as Hg sources in washed cell assays in phosphate buffered saline (pH 7.4), we report how cell-m

254 easured values for glucose concentrations in phosphate-buffered saline (pH approximately 7.4) based o

255 itro radiotracer stability was determined in phosphate-buffered saline, pH 7.4, and in challenge stud

256 by incubation in 50% fetal bovine serum/50% phosphate-buffered saline, pH 7.4, at 37 degrees C.

257 99% radiochemical purity and were stable in phosphate-buffered saline, pH 7.4, for 24 h.

258 Biotinylated IgG was incubated with phosphate-buffered saline, plasma, or plasma treated to

259 of BM cells and intramyocardial injection of phosphate-buffered saline rarely induced arrhythmias.

260 (22.1 +/- 18.6% and 5.3 +/- 3.1%, for FG and phosphate-buffered saline, respectively).

261 ily dissociated from the graft surface after phosphate-buffered saline rinsing.

262 of HCV(VLDF), compared with that mixed with phosphate-buffered saline, showing extracellular assembl

263 ysis using a short gel-filtration column and phosphate buffered saline solution as the mobile phase.

264 properties of the water-soluble chlorins in phosphate-buffered saline solution (pH 7.4) at room temp

265 Mice that received phosphate-buffered saline solution only were included as

266 ide, and the ECL of the 1a film was found in phosphate-buffered saline solution with TPrA.

267 performed in both well-stirred and quiescent phosphate-buffered saline solutions as well as in a 0.3%

268 eceived an intracerebral injection of either phosphate-buffered saline, the neurotoxin saporin (SAP),

269 In whole lens isolated in phosphate-buffered saline, the spacing of the dominant X

270 , Neq)> decreased from approximately 0.24 in phosphate buffered saline to 0.12 in 3,300 mug/ml HA and

271 th a 15% solution of saponin and washed with phosphate buffered saline to release intact parasites.

272 versibility of PRET upon the introduction of phosphate-buffered saline to the channel.

273 wth and prolonged median survival from 13 d (phosphate-buffered saline) to 20 and 29 d for DAR2 and D

274 day for five doses to one wound and vehicle (phosphate-buffered saline) to the other.

275 te in HCG-treated mice compared with that in phosphate buffered saline-treated mice.

276 3-treated P. gingivalis-infected mice versus phosphate buffered saline-treated P. gingivalis-infected

277 with parstatin compared to their respective phosphate-buffered saline-treated controls.

278 improve muscle regeneration, laminin-111 or phosphate-buffered saline-treated laminin-alpha2-deficie

279 antibody-treated animals lived, whereas 3/8 phosphate-buffered saline-treated mice died.

280 face atherosclerosis was noted compared with phosphate-buffered saline-treated mice.

281 rvival in P13-DT-vaccinated mice compared to phosphate-buffered saline-treated or protein carrier-vac

282 creased hippocampal astrocytes compared with phosphate-buffered saline-treated rats, but displayed in

283 m 6TG-treated primary recipients relative to phosphate-buffered saline-treated recipients.

284 e in the rate of repair of the contralateral phosphate-buffered saline-treated wound when compared to

285 rly but increased later compared to those in phosphate-buffered saline-treated, PRCV-infected pigs, c

286 Competition experiments (in 68% DMSO/phosphate buffered saline) using 1 equiv of N-phenethyl-

287 after the surgical induction of OA, LUB:1 or phosphate buffered saline vehicle was administered by in

288 usion of either human recombinant decorin or phosphate-buffered saline (vehicle).

289 -I, anti-IFN-I, isotype control antibody, or phosphate buffered saline was administered to C57BL/6 an

290 unction studies, recombinant IL-7 or control phosphate buffered saline was injected intraperitoneally

291 SEB dissolved in phosphate buffered saline was resolved to levels as low

292 LV-1h153 (1 x 10(7) plaque-forming units) or phosphate buffered saline was tested in an orthotopic mu

293 regulator PG490-88 (MRx-108; 0.75 mg/kg) or phosphate-buffered saline was administered preventilatio

294 tacept (CTLA4-Ig), etanercept (anti-TNF), or phosphate-buffered saline were given to NMRI mice intrav

295 o hundred thousand cells suspended in 20 muL phosphate-buffered saline were mixed with 200 muL Matrig

296 hat does not contain a transgene (Ad312) and phosphate-buffered saline were used as controls.

297 Given time, most of the assemblies in phosphate buffered saline will turn into elongated thin

298 fied essential medium with 1.8 mm calcium or phosphate-buffered saline with 0.18 mm calcium have diff

299 er-resolution microscopy was demonstrated in phosphate-buffered saline without any reducing or oxidiz

300 to protofibrils or amyloid fibrils formed in phosphate-buffered saline without stirring at 37 degrees